IXSBF
INNEXUS BIOTECHNOLOGY INC by InNexus Biotechnology Inc. (IXSBF)
$00
About INNEXUS BIOTECHNOLOGY INC by InNexus Biotechnology Inc. (IXSBF)
InNexus Biotechnology, Inc. develops commercial opportunities based on the field of monoclonal antibodies, naturally occurring proteins that fight infection and disease, utilizing its proprietary DXL and Transmab technologies with following focus areas: ophthalmology, dermatology, and oncology. The company was founded by Alton Charles Morgan on September 5, 1997 and is headquartered in Vancouver, Canada.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
100
Dividend yield
0.00%
Volume
--
Avg. volume
0
P/E ratio
--
INNEXUS BIOTECHNOLOGY INC by InNexus Biotechnology Inc. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
100
Dividend yield
0.00%
Volume
--
Avg. volume
0
P/E ratio
--